Martin G. Kelly

Chief Executive Officer

C-suiteM

US·SEC (Form 4)

Radius Health, Inc.

0

Total declarations

0

Company

—

▲ Purchases (0 ops.)

—

▼ Sales (0 ops.)

Explore the full record of transactions filed by Martin G. Kelly, Chief Executive Officer. Director active across 1 companies, notably Radius Health, Inc.. Aggregated, 2 filings have been published. The latest transaction was disclosed on 21 February 2022 — Attribution. Regulator: SEC (Form 4). All data is openly available.

Declarations2 total

Executives◆GrantRRadius Health, Inc.22SEC

M

Martin G. KellyCEO and President

075,000 shares0

Common Stock

SEC:0001209191-22-013190:0·21 Feb 2022

SEC ↗

Executives◆GrantRRadius Health, Inc.22SEC

M

Martin G. KellyCEO and President

0960,000 shares0

Common Stock

SEC:0001209191-22-012309:0·21 Feb 2022

SEC ↗

2 of 2 declarations

About Martin G. Kelly

Martin G. Kelly is the CEO and President of Radius Health, Inc. In this role, he is responsible for the strategic and operational leadership of the company. Martin brings extensive experience in the biopharmaceutical sector, contributing to innovation and growth at Radius Health. His leadership is essential to achieve the company's objectives and ensure its sustainability.